搜尋
Medtronic PLC
MDT添加自選
82.350USD
-0.940-1.13%
收盤 07/21, 16:00（美東）報價延遲15分鐘
105.69B總市值
22.89本益比TTM
關於 Medtronic PLC 公司
Medtronic Public Limited Company is an Ireland-based company, which provides healthcare technology solutions. The Company’s products category includes Advanced Surgical Technology; Cardiac Rhythm; Cardiovascular; Digestive & Gastrointestinal; Ear, Nose & Throat; General Surgery; Gynecological; Neurological; Oral & Maxillofacial; Patient Monitoring; Renal Care; Respiratory; Spinal & Orthopedic; Surgical Navigation & Imaging; Urological; Product Manuals; Product Ordering & Inquiries; and Product Performance & Advisories. Its products include Cardiac Implantable Electronic Device (CIED) Stabilization, Aortic Stent Graft Products, CareLink Personal Therapy Management Software, CareLink Pro Therapy Management Software. Its services and solutions include Ambulatory Surgery Center Resources, Care Management Services, Digital Connectivity Information Technology (IT) Support, Equipment Services and Support, Innovation Lab, Medtronic Healthcare Consulting, and Office-Based Sinus Surgery.
Medtronic PLC簡介
公司代碼MDT
公司名稱Medtronic PLC
上市日期Nov 21, 1977
CEOMartha (Geoffrey S)
員工數量95000
證券類型Ordinary Share
年結日Nov 21
公司地址Building Two Parkmore Business Park West
城市DUBLIN
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家Ireland
郵編H91 4K49
電話1135314381700
網址https://www.medtronic.com/
公司代碼MDT
上市日期Nov 21, 1977
CEOMartha (Geoffrey S)
Medtronic PLC公司高管
名稱
名稱/職務
職務
持股
持股變動
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.95M
-2.15%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
575.08K
+4.68%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
59.78K
-12.50%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.77%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
50.75K
+3.75%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
42.14K
+4.52%
Mr. Scott C. Donnelly
Mr. Scott C. Donnelly
Independent Director
Independent Director
23.61K
+8.06%
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Dr. Elizabeth G. (Betsy) Nabel, M.D.
Independent Director
Independent Director
19.54K
+9.74%
Mr. Kevin E. Lofton
Mr. Kevin E. Lofton
Independent Director
Independent Director
10.10K
+18.86%
Ms. Lidia L. Fonseca
Ms. Lidia L. Fonseca
Independent Director
Independent Director
7.63K
+24.97%
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Geoffrey S. (Geoff) Martha
Mr. Geoffrey S. (Geoff) Martha
Executive Chairman of the Board, Chief Executive Officer
Executive Chairman of the Board, Chief Executive Officer
1.95M
-2.15%
Mr. Brett A. Wall
Mr. Brett A. Wall
Executive Vice President, President - Neuroscience Portfolio
Executive Vice President, President - Neuroscience Portfolio
575.08K
+4.68%
Mr. Michael Marinaro
Mr. Michael Marinaro
Executive Vice President, President - Medical Surgical Portfolio and Americas
Executive Vice President, President - Medical Surgical Portfolio and Americas
59.78K
-12.50%
Mr. Ivan K. Fong
Mr. Ivan K. Fong
Executive Vice President, General Counsel, Corporate Secretary
Executive Vice President, General Counsel, Corporate Secretary
52.34K
-6.77%
Mr. Kendall J. (Ken) Powell
Mr. Kendall J. (Ken) Powell
Independent Director
Independent Director
50.75K
+3.75%
Mr. Craig Arnold
Mr. Craig Arnold
Lead Independent Director
Lead Independent Director
42.14K
+4.52%
常見問題
Medtronic PLC的前五大股東是誰？
Medtronic PLC的前五大股東如下：Mr. Geoffrey S. (Geoff) Martha
有多少機構持有Medtronic PLC(MDT)的股份？
截至2026Q1，共有3854家機構持有Medtronic PLC的股份，合計持有的股份價值約為1.12B，占公司總股份的86.90% 。與2025Q4相比，機構持股有所增加，增幅為-35115160.00。
哪個業務部門對Medtronic PLC的收入貢獻最大？
在2026Q1，Cardiac Rhythm & Heart Failure業務部門對Medtronic PLC的收入貢獻最大，創收1.86B，占總收入的20.58% 。